REKOM BIOTECH signs a China distribution agreement

8/20/2020

Rekom Biotech and Ambigen have closed an exclusive distribution agreement on August 28th, 2020, for the commercialization of Rekom products in China.

China represents one of the largest in vitro diagnostics markets in the Asia-Pacific region and this trend is expected to continue over the forecast period. For Rekom Biotech it would be an honor to be able to offer high quality raw material to all these IVD test manufacturers that are in search of the best product for their assays. We are confident that our partnership with Ambigen will provide our chinese customers with an outstanding quality and exceptional customer service including pre and post-sale support, guaranteeing the best possible experience.